Advances in healthcare information systems and administration book series,
Journal Year:
2024,
Volume and Issue:
unknown, P. 261 - 282
Published: Feb. 9, 2024
Recent
years
have
witnessed
a
significant
convergence
of
artificial
intelligence
(AI)
within
the
healthcare
sector.
This
chapter
explores
transformative
potential
and
challenges
posed
by
these
intelligent
technologies
in
healthcare.
It
various
domains
such
as
predictive
analytics,
telemedicine,
personalized
medicine,
enhancement
operational
efficiencies.
The
findings
underscore
AI
smart
revolutionizing
delivery.
carries
extensive
implications
for
Healthcare
practitioners
administrators
can
leverage
insights
to
strategically
incorporate
solutions,
aiming
improve
patient
outcomes
enhance
organizational
efficiency.
Additionally,
provide
valuable
guidance
policymakers
stakeholders,
informing
creation
guidelines
standards
that
foster
innovation,
ensure
safety,
protect
data
security.
Therefore,
this
is
an
essential
guide
effectively
embracing
role
advancing
practices.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Feb. 21, 2024
Abstract
Inflammation-associated
diseases
encompass
a
range
of
infectious
and
non-infectious
inflammatory
diseases,
which
continuously
pose
one
the
most
serious
threats
to
human
health,
attributed
factors
such
as
emergence
new
pathogens,
increasing
drug
resistance,
changes
in
living
environments
lifestyles,
aging
population.
Despite
rapid
advancements
mechanistic
research
development
for
these
current
treatments
often
have
limited
efficacy
notable
side
effects,
necessitating
more
effective
targeted
anti-inflammatory
therapies.
In
recent
years,
nanotechnology
has
provided
crucial
technological
support
prevention,
treatment,
detection
inflammation-associated
diseases.
Various
types
nanoparticles
(NPs)
play
significant
roles,
serving
vaccine
vehicles
enhance
immunogenicity
carriers
improve
targeting
bioavailability.
NPs
can
also
directly
combat
pathogens
inflammation.
addition,
facilitated
biosensors
pathogen
imaging
techniques
This
review
categorizes
characterizes
different
NPs,
summarizes
their
applications
It
discusses
challenges
associated
with
clinical
translation
this
field
explores
latest
developments
prospects.
conclusion,
opens
up
possibilities
comprehensive
management
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 2, 2024
Abstract
Cancer
remains
a
significant
global
public
health
concern,
with
increasing
incidence
and
mortality
rates
worldwide.
Oxidative
stress,
characterized
by
the
production
of
reactive
oxygen
species
(ROS)
within
cells,
plays
critical
role
in
development
cancer
affecting
genomic
stability
signaling
pathways
cellular
microenvironment.
Elevated
levels
ROS
disrupt
homeostasis
contribute
to
loss
normal
functions,
which
are
associated
initiation
progression
various
types
cancer.
In
this
review,
we
have
focused
on
elucidating
downstream
that
influenced
oxidative
stress
carcinogenesis.
These
include
p53,
Keap1-NRF2,
RB1,
p21,
APC,
tumor
suppressor
genes,
cell
type
transitions.
Dysregulation
these
can
lead
uncontrolled
growth,
impaired
DNA
repair
mechanisms,
evasion
death,
all
hallmark
features
development.
Therapeutic
strategies
aimed
at
targeting
emerged
as
area
investigation
for
molecular
biologists.
The
objective
is
limit
response
time
cancer,
including
liver,
breast,
prostate,
ovarian,
lung
cancers.
By
modulating
redox
balance
restoring
homeostasis,
it
may
be
possible
mitigate
damaging
effects
enhance
efficacy
treatments.
targeted
therapies
interventions
specifically
address
impact
holds
great
promise
improving
patient
outcomes.
approaches
antioxidant-based
treatments,
redox-modulating
agents,
restore
function
affected
stress.
summary,
understanding
carcinogenesis
process
through
therapeutic
utmost
importance
combating
Further
research
needed
unravel
complex
mechanisms
underlying
stress-related
develop
effective
translated
into
clinical
applications
management
treatment
Life Sciences,
Journal Year:
2024,
Volume and Issue:
352, P. 122899 - 122899
Published: July 9, 2024
This
comprehensive
review
provides
an
in-depth
analysis
of
how
nanotechnology
has
revolutionized
cancer
theragnostic,
which
combines
diagnostic
and
therapeutic
methods
to
customize
treatment.
The
study
examines
the
unique
attributes,
uses,
difficulties
linked
different
types
nanoparticles,
including
gold,
iron
oxide,
silica,
Quantum
dots,
Carbon
nanotubes,
liposomes,
in
context
In
addition,
paper
progression
nanotheranostics,
emphasizing
its
uses
precise
medication
administration,
photothermal
therapy,
sophisticated
such
as
MRI,
CT,
fluorescence
imaging.
Moreover,
article
highlights
capacity
nanoparticles
improve
effectiveness
drugs,
reduce
overall
toxicity
body,
open
up
new
possibilities
for
treating
by
releasing
drugs
a
controlled
manner
targeting
specific
areas.
Furthermore,
it
tackles
concerns
regarding
compatibility
their
potential
harmful
effects,
significance
continuous
nanotherapeutic
use
medical
treatments.
finishes
outlining
future
applications
predictive
oncology
customized
medicine.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(2), P. 223 - 223
Published: Feb. 4, 2024
Niosomes
are
vesicular
nanocarriers,
biodegradable,
relatively
non-toxic,
stable,
and
inexpensive,
that
provide
an
alternative
for
lipid-solid
carriers
(e.g.,
liposomes).
may
resolve
issues
related
to
the
instability,
fast
degradation,
bioavailability,
insolubility
of
different
drugs
or
natural
compounds.
can
be
very
efficient
potential
systems
specific
delivery
anticancer,
antioxidant,
anti-inflammatory,
antimicrobial,
antibacterial
molecules.
This
review
aims
present
overview
their
composition,
most
common
formulation
techniques,
as
well
recent
utilizations
in
cancer
therapy.
Small,
Journal Year:
2024,
Volume and Issue:
20(35)
Published: May 1, 2024
Abstract
Cancer
nanovaccines
represent
a
promising
frontier
in
cancer
immunotherapy,
utilizing
nanotechnology
to
augment
traditional
vaccine
efficacy.
This
review
comprehensively
examines
the
current
state‐of‐the‐art
nanovaccine
development,
elucidating
innovative
strategies
and
technologies
employed
their
design.
It
explores
both
preclinical
clinical
advancements,
emphasizing
key
studies
demonstrating
potential
elicit
robust
anti‐tumor
immune
responses.
The
study
encompasses
various
facets,
including
integrating
biomaterial‐based
nanocarriers
for
antigen
delivery,
adjuvant
selection,
impact
of
nanoscale
properties
on
performance.
Detailed
insights
into
complex
interplay
between
tumor
microenvironment
responses
are
provided,
highlighting
challenges
opportunities
optimizing
therapeutic
outcomes.
Additionally,
presents
thorough
analysis
ongoing
trials,
presenting
snapshot
landscape.
By
curating
latest
scientific
findings
developments,
this
aims
serve
as
comprehensive
resource
researchers
clinicians
engaged
advancing
immunotherapy.
Integrating
design
holds
immense
promise
revolutionizing
treatment
paradigms,
provides
timely
update
evolving
landscape
nanovaccines.
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
95, P. 105599 - 105599
Published: March 26, 2024
Despite
considerable
progress
in
patient
care,
the
global
incidence
of
various
cancer
types
continues
to
rise.
Developing
safer
and
more
efficient
anti-cancer
treatment
approaches
are
great
interest.
In
recent
decades,
nanotechnology
has
emerged
as
a
promising
innovative
medical
approach
for
diagnosis
treatment.
However,
nanomedicine
advances,
it
is
important
understand
address
challenges.
Herein,
we
identify
gaps
current
understanding
effectiveness
on
clinical
outcomes
provide
an
outlook
improved
application
medicine.
We
discuss
use
different
nanoparticles
therapy
impact
efficiency
existing
treatments,
such
chemotherapeutic,
anti-angiogenic,
immunotherapeutic
drugs,
radiotherapy.
Additionally,
update
status
trials
nanoparticle-based
treatments
provided.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(5), P. 504 - 504
Published: April 23, 2024
Despite
the
significant
progress
in
fields
of
biology,
physiology,
molecular
medicine,
and
pharmacology;
designation
properties
nitrogen
monoxide
regulation
life-supporting
functions
organism;
numerous
works
devoted
to
this
molecule,
there
are
still
many
open
questions
field.
It
is
widely
accepted
that
nitric
oxide
(•NO)
a
unique
molecule
that,
despite
its
extremely
simple
structure,
has
wide
range
body,
including
cardiovascular
system,
central
nervous
system
(CNS),
reproduction,
endocrine
respiration,
digestion,
etc.
Here,
we
systematize
•NO,
contributing
conditions
physiological
norms,
as
well
various
pathological
processes,
mechanisms
cytoprotection
cytodestruction.
Current
experimental
clinical
studies
contradictory
describing
role
•NO
pathogenesis
diseases
CNS.
We
describe
cytoprotective
action
associated
with
expression
antiapoptotic
chaperone
proteins
mitochondrial
function.
The
most
prominent
cytodestruction—the
initiation
nitrosative
oxidative
stresses,
production
reactive
oxygen
species,
participation
apoptosis
mitosis.
formation
endothelial
dysfunction
also
considered.
Moreover,
focus
on
ways
pharmacological
modulation
nitroxidergic
allow
for
decrease
cytodestructive
increase
ones.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: May 28, 2024
Triple-negative
breast
cancer
(TNBC)
poses
significant
challenges
in
oncology
due
to
its
aggressive
nature,
limited
treatment
options,
and
poorer
prognosis
compared
other
subtypes.
This
comprehensive
review
examines
the
therapeutic
diagnostic
landscape
of
TNBC,
highlighting
current
strategies,
emerging
therapies,
future
directions.
Targeted
including
PARP
inhibitors,
immune
checkpoint
EGFR
hold
promise
for
personalized
approaches.
Challenges
identifying
novel
targets,
exploring
combination
developing
predictive
biomarkers
must
be
addressed
optimize
targeted
therapy
TNBC.
Immunotherapy
represents
a
transformative
approach
TNBC
treatment,
yet
biomarker
identification,
overcoming
resistance
persist.
Precision
medicine
approaches
offer
opportunities
tailored
based
on
tumor
biology,
but
integration
multi-omics
data
clinical
implementation
present
requiring
innovative
solutions.
Despite
these
challenges,
ongoing
research
efforts
collaborative
initiatives
hope
improving
outcomes
advancing
strategies
By
addressing
complexities
biology
effective
approaches,
treatments
can
realized,
ultimately
enhancing
lives
patients.
Continued
research,
trials,
interdisciplinary
collaborations
are
essential
realizing
this
vision
making
meaningful
progress
management.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 6099 - 6126
Published: June 1, 2024
Abstract:
The
relentless
pursuit
of
effective
cancer
diagnosis
and
treatment
strategies
has
led
to
the
rapidly
expanding
field
nanotechnology,
with
a
specific
focus
on
nanocomposites.
Nanocomposites,
combination
nanomaterials
diverse
properties,
have
emerged
as
versatile
tools
in
oncology,
offering
multifunctional
platforms
for
targeted
delivery,
imaging,
therapeutic
interventions.
Nanocomposites
exhibit
great
potential
early
detection
accurate
imaging
diagnosis.
Integrating
various
modalities,
such
magnetic
resonance
(MRI),
computed
tomography
(CT),
fluorescence
into
nanocomposites
enables
development
contrast
agents
enhanced
sensitivity
specificity.
Moreover,
functionalizing
targeting
ligands
ensures
selective
accumulation
tumor
tissues,
facilitating
precise
diagnostic
accuracy.
On
front,
revolutionized
by
overcoming
traditional
challenges
associated
drug
delivery.
controlled
release
from
nanocomposite
carriers
enhances
bioavailability,
reduces
systemic
toxicity,
improves
overall
efficacy.
Additionally,
integration
stimuli-responsive
components
within
site-specific
triggered
unique
microenvironment
tumor.
Despite
remarkable
progress
field,
biocompatibility,
scalability,
long-term
safety
profiles
remain.
This
article
provides
comprehensive
overview
recent
developments,
challenges,
prospects,
emphasizing
transformative
revolutionizing
landscape
diagnostics
therapeutics.
In
Conclusion,
integrating
heralds
new
era
precision
medicine.
Keywords:
nanocomposites,
cancer,
diagnosis,
therapy,
nanoparticles,
theranostic
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(7), P. 723 - 723
Published: July 4, 2024
Breast
cancer
remains
the
most
prevalent
among
women
worldwide,
driving
urgent
need
for
innovative
approaches
to
diagnosis
and
treatment.
This
review
highlights
pivotal
role
of
nanoparticles
in
revolutionizing
breast
management
through
advancements
interconnected
including
targeted
therapy,
imaging,
personalized
medicine.
Nanoparticles,
with
their
unique
physicochemical
properties,
have
shown
significant
promise
addressing
current
treatment
limitations
such
as
drug
resistance
nonspecific
systemic
distribution.
Applications
range
from
enhancing
delivery
systems
sustained
release
developing
diagnostic
tools
early
precise
detection
metastases.
Moreover,
integration
into
photothermal
therapy
synergistic
use
existing
treatments,
immunotherapy,
illustrate
transformative
potential
care.
However,
journey
towards
clinical
adoption
is
fraught
challenges,
chemical
feasibility,
biodistribution,
efficacy,
safety
concerns,
scalability,
regulatory
hurdles.
delves
state
nanoparticle
research,
applications
diagnosis,
obstacles
that
must
be
overcome
integration.